N@N

Market Maker Surveillance Report. VRTX, UBS, ESRX, DHI, YRCW, SNGX, Bearishly Biased Price Friction For Thursday, September 15

^{Published on 2011-09-15 18:00:43 - WOPRAI}
 

September 15, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4261 companies with "abnormal" market making, 3898 companies with positive Friction Factors and 2153 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX), UBS AG-REG (NYSE:UBS), EXPRESS SCRIPTS INC (NASDAQ:ESRX), DR HORTON INC (NYSE:DHI), YRC WORLDWIDE INC (NASDAQ:YRCW), SOLIGENIX INC (OTC:SNGX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     VRTX       $-0.370      -0.73%       1,600,834       58.41%       1,110,136       40.50%       490,698         Abnormal
     UBS        $-1.280      -10.09%      10,282,318      34.99%       9,391,211       31.96%       891,107         Abnormal
     ESRX       $-1.280      -3.00%       13,828,612      51.41%       12,743,213      47.37%       1,085,399       Abnormal
     DHI        $-0.070      -0.72%       2,783,096       36.53%       2,019,056       26.50%       764,040         Abnormal
     YRCW       $-0.050      -13.52%      6,597,545       58.22%       4,734,782       41.78%       1,862,763       Abnormal
     SNGX       $-0.207      -78.11%      29,492,072      51.58%       26,396,769      46.17%       3,095,303       Abnormal

For example, the chart above shows VRTX with 490,698 greater shares of buying than selling (NetVol) and the stock price was down $-0.37000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more buying than selling should cause prices to rise.

VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) - Vertex Pharmaceuticals Incorporated engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide. Its product pipeline includes Telaprevir (VX-950), a Phase III clinical trial product for the treatment of hepatitis C virus (HCV) infection; VX-222, a Phase IIa clinical trial product targeting HCV infection; VX-770, a Phase III clinical trial candidate for the treatment of cystic fibrosis; and VX-809, a Phase IIa clinical trial product targeting cystic fibrosis. The companys products also comprise VX-509, a Phase IIa clinical trial product for the treatment of rheumatoid arthritis; VX-765, a Phase IIa clinical trial product targeting epilepsy; and VX-759, a Phase I clinical trial product for the treatment of HCV infection. It has collaboration agreements with Janssen Pharmaceutica, N.V.; Mitsubishi Tanabe Pharma Corporation; Cystic Fibrosis Foundation Therapeutics Incorporated; Merck & Co., Inc.; and GlaxoSmithKline plc. The company was founded in 1989 and is headquartered in Cambridge, Massachusetts.

UBS AG-REG (NYSE:UBS) - UBS AG, a financial services firm, provides wealth management, asset management, and investment banking services to private, corporate, and institutional clients worldwide. The company also involves in retail and commercial banking in Switzerland. Its Wealth Management & Swiss Bank divisions wealth management business caters to high net worth individuals worldwide (except the Americas) whether they are investing internationally or in their home country. This division offers these clients a range of tailored advice and investment services. Its Swiss Bank business provides a set of banking services for Swiss individual and corporate clients. The companys Wealth Management Americas division offers products and services specifically designed to address the needs of high net worth and ultra high net worth individuals, and families. It includes Wealth Management U.S., domestic Canada, and the international business booked in the United States. UBS AGs Global Asset Management division provides investment solutions to financial intermediaries and institutional clients worldwide. It offers investment capabilities across various traditional and alternative asset classes, including equity, fixed income, currency, hedge fund, real estate, infrastructure, and private equity investment capabilities that could also be combined in multi-asset strategies. The companys Investment Bank division provides securities products and research in equities, fixed income, rates, foreign exchange, and metals. It also offers advisory services, as well as access to the worlds capital markets for corporate, institutional, intermediary, and alternative asset management clients. UBS AG operates in approximately 50 countries. The company was founded in 1862 and is based in Zurich, Switzerland.

EXPRESS SCRIPTS INC (NASDAQ:ESRX) - Express Scripts, Inc. provides a range of pharmacy benefit management (PBM) services in North America. The companys PBM services include retail network pharmacy management and retail drug card programs; home delivery pharmacy services; specialty pharmacy services; patient care contact centers; benefit plan design and consultation; drug formulary management; compliance and therapy management programs; information reporting and analysis programs; rebate programs, electronic claims processing, and drug utilization review; consumer health and drug information; bio-pharma services, including reimbursement and customized logistics solutions; medication therapy and safety through pharmacogenomics; and assistance programs for low-income patients. It also engages in the distribution of pharmaceuticals and medical supplies to providers and clinics; fertility pharmaceuticals requiring special handling or packaging; and sample units to physicians, as well as the verification of practitioner licensure, healthcare account administration, and implementation of consumer-directed healthcare solutions. It serves HMOs, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers compensation plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, and retina specialists. Express Scripts was founded in 1986 and is headquartered in St. Louis, Missouri.

DR HORTON INC (NYSE:DHI) - D.R. Horton, Inc. operates as a homebuilding company in the United States. The companys Homebuilding segment engages in the acquisition and development of land, and construction and sale of residential homes on the land in 26 states and 72 markets in the United States primarily under the name of D.R. Horton and Americas Builder. This segment also builds traditional single-family detached homes, as well as attached homes, such as town homes, duplexes, triplexes and condominiums, which share common walls and roofs. Its Financial Services segment involves in originating and selling mortgages, as well as provides title insurance policies, examination, and closing services to homebuyers. The company markets and sells its homes through commissioned employees and independent real estate brokers. The company was founded in 1978 and is based in Fort Worth, Texas.

YRC WORLDWIDE INC (NASDAQ:YRCW) - YRC Worldwide Inc., through its subsidiaries, provides various transportation services worldwide. The companys YRC National Transportation unit offers a range of services for the transportation of industrial, commercial, and retail goods, such as apparel, appliances, automotive parts, chemicals, food, furniture, glass, machinery, metal, metal products, non-bulk petroleum products, rubber, textiles, wood, and other manufactured products. It serves manufacturing, wholesale, retail, and government customers. As of December 31, 2009, it had 11704 owned tractors, 1239 leased tractors, 50083 owned trailers, and 3244 leased trailers. Its YRC Regional Transportation units service portfolio includes regional delivery, which comprises next-day local area delivery and second-day services, consolidation/distribution services, protect-from-freezing and hazardous materials handling, and various specialized offerings; expedited delivery, that comprises day-definite, hour-definite, and time definite capabilities; inter-regional delivery; cross-border delivery; and operation of my.yrcregional.com and NewPenn.com, which are e-commerce Websites offering online resources to manage transportation activity. The companys YRC Logistics units service portfolio consists of distribution services that include flow through and pool distribution, dedicated warehousing, and value-added services; global services, which comprise international freight forwarding, customs brokerage, and value-added services; and transportation services, such as truckload brokerage, domestic freight forwarding, and transportation management. Its YRC Truckload unit provides customized truckload services on regional and national level through the use of company and team-based drivers. The company was founded in 1924 and is headquartered in Overland Park, Kansas.

SOLIGENIX INC (OTC:SNGX) - Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development of products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, as well as biodefense vaccines and therapeutics. The company is developing biotherapeutic products, such as orBec (oral beclomethasone dipropionate) for the treatment and prevention of acute gastrointestinal Graft-versus-Host-Disease, as well as for treatment of chronic GI GVHD; SGX201 for the prevention of acute radiation enteritis; and Lipid Polymer Micelle drug delivery technology for the oral delivery of leuprolide for the treatment of prostate cancer and endometriosis. Its biodefense product line comprises RiVax, a recombinant subunit vaccine designed to protect against the lethal effects of exposure to ricin toxin; and SGX 202, which is in pre-clinical stage for treating radiation injuries. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in September 2009. Soligenix was founded in 1987 and is headquartered in Princeton, New Jersey.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net